SUrvey of renal Biopsy registry database and Anticancer dRUg therapy in Japan (SUBARU-J study)
Our registry analysis highlighted various presentations of biopsy-proven kidney complications associated with anticancer drug therapy. Clinicians should be aware of worse outcomes associated with CTx-TMA and the prognostic role of PPI use.
Authors
- Hitoshi Sugiyama (ORCID: https://orcid.org/0000-0002-4127-6471)
- Kenar D. Jhaveri (ORCID: https://orcid.org/0000-0003-1578-0524)
- Teruhiko Mizumoto
- Masashi Mukoyama (ORCID: https://orcid.org/0000-0001-5636-4039)
- Takeshi Matsubara (ORCID: https://orcid.org/0000-0001-7407-2451)
- Takashige Kuwabara (ORCID: https://orcid.org/0000-0003-3507-4328)
- Tomohiro Murata
- Shoichi Maruyama (ORCID: https://orcid.org/0000-0002-8858-632X)
- Motoko Yanagita (ORCID: https://orcid.org/0000-0002-0339-9008)
- Toshiyuki Imasawa (ORCID: https://orcid.org/0000-0002-6620-7069)
- Naoki Sawa
- Tatsuo Tsukamoto (ORCID: https://orcid.org/0000-0003-2896-5595)
- Hiroshi Sato (ORCID: https://orcid.org/0000-0001-7706-158X)
- Naoka Murakami (ORCID: https://orcid.org/0000-0001-8168-5811)
- Yoshikazu Miyasato
- Mariko Miyazaki (ORCID: https://orcid.org/0000-0001-6509-1706)
- Tomoko Kanki
Institutions
- Northwell Health (US)
- Mie University (JP)
- Kawasaki Medical School (JP)
- Tohoku University (JP)
- Washington University in St. Louis (US)
- Kyoto University (JP)
- National Hospital Organization (JP)
- Kitano Hospital (JP)
- Toranomon Hospital (JP)
- Nagoya University (JP)
- Kawasaki College of Allied Health Professions (JP)
- Kumamoto University (JP)
Publication Details
- Journal
- Clinical Kidney Journal
- Published
- 2024-11-28
- DOI
- https://doi.org/10.1093/ckj/sfae327
- Citations
- 3
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.26